Log in

Relevant bibliographies by topics / Dual diagnosis – Patients – Scotland / Journal articles

Journal articles on the topic 'Dual diagnosis – Patients – Scotland'

To see the other types of publications on this topic, follow the link: Dual diagnosis – Patients – Scotland.

Author: Grafiati

Published: 26 July 2024

Last updated: 28 July 2024

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the top 50 journal articles for your research on the topic 'Dual diagnosis – Patients – Scotland.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Browse journal articles on a wide variety of disciplines and organise your bibliography correctly.

1

Ming, Timothy, Tom Denee, Gemma Scott, Joachim Morrens, and Christopher Weatherburn. "Epidemiology and current treatment patterns of treatment-resistant depression in Scotland: a CPRD study." BJPsych Open 7, S1 (June 2021): S334. http://dx.doi.org/10.1192/bjo.2021.876.

Full text

Abstract:

AimsTo assess the incidence and treatments currently used in clinical practice for the treatment of treatment-resistant depression (TRD) in Scotland.BackgroundPatients with major depressive disorder (MDD) who have not responded to at least two successive antidepressant (AD) treatments in a single episode are described as having Treatment-Resistant Depression (TRD). Epidemiological data on TRD in Scotland is lacking. Furthermore, there is no data to our knowledge on therapies prescribed in Scottish clinical practice to treat TRD.MethodA retrospective, longitudinal cohort study was conducted using Clinical Practice Research Datalink (CPRD) medical records. Adult patients were indexed on AD prescription, requiring MDD diagnosis within 90 days, from Jan 2011-May 2018 with 360-day baseline and 180-day minimum follow-up periods. Failure of ≥2 adequate oral AD regimens following indexing constituted TRD classification. Incidence rates of MDD and TRD (within the MDD cohort) and treatment lines following TRD classification were derived.ResultThe analysis included 20,059 patients with MDD (mean age 44 years, 63% female, median follow-up 59 months); 1,374 (6.8%) were classified as TRD. Median time-to-TRD classification was 25 months. The incidence rate of MDD was 15.9 per 1,000 patient-years and for TRD was 14.7 per 1,000 MDD-patient-years. For all first four post-TRD treatment lines, SSRI monotherapy was the most commonly prescribed therapy, followed by combination (dual/triple) therapy and augmentation therapy (at least one oral AD supplemented with lithium, an antipsychotic or an anticonvulsant therapy). At first-line of TRD treatment, 1,050 (76.4%) patients received monotherapy AD, 212 (15.4%) received combination AD therapy and 112 (8.2%) received augmentation therapy. The most common monotherapy treatments at first-line TRD were sertraline (15.6%), mirtazapine (13.8%), fluoxetine (12.2%) and venlafaxine (11.6%). Among combination therapies, mirtazapine, venlafaxine, sertraline and amitriptyline were frequently used. Among the TRD and MDD cohort, no somatic treatments were coded in CPRD, although the use of these treatments was likely underestimated.ConclusionMonotherapy AD treatment was the most common therapy type for all four post-TRD treatment lines. These data support the need for new treatments that can achieve and maintain therapeutic response, and avoid continuous cycling through similar AD therapies.This study was sponsored by Janssen Cilag Ltd.

APA, Harvard, Vancouver, ISO, and other styles

2

Stockfisch, Robert, Marc Galanter, and Harold Lifshutz. "Trends in Dual-Diagnosis Patients." American Journal on Addictions 4, no. 4 (October 1995): 356–57. http://dx.doi.org/10.1111/j.1521-0391.1995.tb00275.x.

Full text

APA, Harvard, Vancouver, ISO, and other styles

3

Gimelfarb, Y., Z. Natan, and Y. Baruch. "Suicide in dual diagnosis patients." European Psychiatry 22 (March 2007): S193—S194. http://dx.doi.org/10.1016/j.eurpsy.2007.01.640.

Full text

APA, Harvard, Vancouver, ISO, and other styles

4

Brunette, Mary F., and Douglas L. Noordsy. "ADHD in Dual Diagnosis Patients." Journal of Dual Diagnosis 6, no. 3-4 (December 30, 2010): 192–95. http://dx.doi.org/10.1080/15504263.2010.540773.

Full text

APA, Harvard, Vancouver, ISO, and other styles

5

Soyka, Michael. "Dual Diagnosis in Patients with Schizophrenia." CNS Drugs 5, no. 6 (June 1996): 414–25. http://dx.doi.org/10.2165/00023210-199605060-00002.

Full text

APA, Harvard, Vancouver, ISO, and other styles

6

Schneier, Max. "Better Treatment for Dual Diagnosis Patients." Psychiatric Services 51, no. 9 (September 2000): 1079. http://dx.doi.org/10.1176/appi.ps.51.9.1079.

Full text

APA, Harvard, Vancouver, ISO, and other styles

7

Donati, R., H. P. Hirsbrunner, J. Brodbeck, F. Moggi, and K. M. Bachmann. "Treatment Motivation among Dual Diagnosis Patients." European Psychiatry 12, S2 (1997): 200s. http://dx.doi.org/10.1016/s0924-9338(97)80611-6.

Full text

APA, Harvard, Vancouver, ISO, and other styles

8

Krysta, K., I. Krupka-Matuszczyk, A. Klasik, M. Matuszczyk, and M. Sygut. "Continuous attention in dual diagnosis patients." European Psychiatry 22 (March 2007): S119. http://dx.doi.org/10.1016/j.eurpsy.2007.01.381.

Full text

APA, Harvard, Vancouver, ISO, and other styles

9

Goldsmith, R. Jeffrey, and Vamsi Garlapati. "Behavioral interventions for dual-diagnosis patients." Psychiatric Clinics of North America 27, no. 4 (December 2004): 709–25. http://dx.doi.org/10.1016/j.psc.2004.07.002.

Full text

APA, Harvard, Vancouver, ISO, and other styles

10

Zimberg, Sheldon. "A Dual Diagnosis Typology to Improve Diagnosis and Treatment of Dual Disorder Patients." Journal of Psychoactive Drugs 31, no. 1 (January 1999): 47–51. http://dx.doi.org/10.1080/02791072.1999.10471725.

Full text

APA, Harvard, Vancouver, ISO, and other styles

11

Taggart, Caelan, Andreas Roos, Erik Kadesjö, Atul Anand, Ziwen Li, Dimitrios Doudesis, Kuan Ken Lee, et al. "Application of the Universal Definition of Myocardial Infarction in Clinical Practice in Scotland and Sweden." JAMA Network Open 7, no. 4 (April 8, 2024): e245853. http://dx.doi.org/10.1001/jamanetworkopen.2024.5853.

Full text

Abstract:

ImportanceWhether the diagnostic classifications proposed by the universal definition of myocardial infarction (MI) to identify type 1 MI due to atherothrombosis and type 2 MI due to myocardial oxygen supply-demand imbalance have been applied consistently in clinical practice is unknown.ObjectiveTo evaluate the application of the universal definition of MI in consecutive patients with possible MI across 2 health care systems.Design, Setting, and ParticipantsThis cohort study used data from 2 prospective cohorts enrolling consecutive patients with possible MI in Scotland (2013-2016) and Sweden (2011-2014) to assess accuracy of clinical diagnosis of MI recorded in hospital records for patients with an adjudicated diagnosis of type 1 or type 2 MI. Data were analyzed from August 2022 to February 2023.Main Outcomes and MeasuresThe main outcome was the proportion of patients with a clinical diagnosis of MI recorded in the hospital records who had type 1 or type 2 MI, adjudicated by an independent panel according to the universal definition. Characteristics and risk of subsequent MI or cardiovascular death at 1 year were compared.ResultsA total of 50 356 patients were assessed. The cohort from Scotland included 28 783 (15 562 men [54%]; mean [SD] age, 60 [17] years), and the cohort from Sweden included 21 573 (11 110 men [51%]; mean [SD] age, 56 [17] years) patients. In Scotland, a clinical diagnosis of MI was recorded in 2506 of 3187 patients with an adjudicated diagnosis of type 1 MI (79%) and 122 of 716 patients with an adjudicated diagnosis of type 2 MI (17%). Similar findings were observed in Sweden, with 970 of 1111 patients with adjudicated diagnosis of type 1 MI (87%) and 57 of 251 patients with adjudicated diagnosis of type 2 MI (23%) receiving a clinical diagnosis of MI. Patients with an adjudicated diagnosis of type 1 MI without a clinical diagnosis were more likely to be women (eg, 336 women [49%] vs 909 women [36%] in Scotland; P &lt; .001) and older (mean [SD] age, 71 [14] v 67 [14] years in Scotland, P &lt; .001) and, when adjusting for competing risk from noncardiovascular death, were at similar or increased risk of subsequent MI or cardiovascular death compared with patients with a clinical diagnosis of MI (eg, 29% vs 18% in Scotland; P &lt; .001).Conclusions and RelevanceIn this cohort study, the universal definition of MI was not consistently applied in clinical practice, with a minority of patients with type 2 MI identified, and type 1 MI underrecognized in women and older persons, suggesting uncertainty remains regarding the diagnostic criteria or value of the classification.

APA, Harvard, Vancouver, ISO, and other styles

12

Price, Scott A., and Nancy C. Brahm. "Antipsychotic Treatment of Adolescent Dual Diagnosis Patients." Journal of Pediatric Pharmacology and Therapeutics 16, no. 4 (October 1, 2011): 226–36. http://dx.doi.org/10.5863/1551-6776-16.4.226.

Full text

Abstract:

BACKGROUND A diagnosis of schizophrenia requires development of a pharmacotherapy regimen that balances many factors in the therapeutic decision-making process. Patient age and the presence or absence of comorbid chemical dependency represent two factors. Comorbid chemical dependency can have a profound impact on the successful treatment of schizophrenia, making patients with dual diagnoses of schizophrenia and chemical dependence a uniquely challenging population. There is little information regarding treatment of schizophrenia and chemical dependence in the pediatric population. Existing data from pediatric and adult populations may facilitate a well-guided and knowledgeable approach to treating pediatric dual diagnosis patients. METHODS A review of the literature for medication trials evaluating antipsychotic medication used to treat schizophrenia in childhood and adolescence as well as antipsychotic use in the treatment of the dual diagnoses of schizophrenia and chemical dependence was done. Databases for Ovid MEDLINE, PubMed, and PsycInfo were searched using the terms “addiction,” “adolescence,” “childhood,” “dual diagnosis,” “schizophrenia,” and “substance abuse.” Results were limited to English-language articles. RESULTS Seven articles were identified related to psychotic disorders and substance abuse in pediatric populations. Psychosis measurement instruments included the Brief Psychiatric Rating Scale, Positive and Negative Syndrome Scale, and Clinical Global Impression. Mean improvements were insignificant in most cases. Medication trials included clozapine, olanzapine, risperidone, and molindone. Trial safety concerns included metabolic effects, increased prolactin levels, and akathisia. One study with random assignment to olanzapine was discontinued early because of substantial weight gain without evidence of superior efficacy. Clozapine treatment was associated with more adverse drug events. CONCLUSION There is a great need for more research and use of available data to develop safe and effective treatment guidelines for childhood and adolescent dual diagnosis patients. When appropriate decisions are made regarding treatment of patients with comorbid schizophrenia and chemical dependence, both conditions may benefit with increased remission.

APA, Harvard, Vancouver, ISO, and other styles

13

Subodh, BN, Nidhi Sharma, and Raghav Shah. "Psychosocial interventions in patients with dual diagnosis." Indian Journal of Psychiatry 60, no. 8 (2018): 494. http://dx.doi.org/10.4103/psychiatry.indianjpsychiatry_18_18.

Full text

APA, Harvard, Vancouver, ISO, and other styles

14

Renner, John A. "Training Psychiatrists to Treat Dual Diagnosis Patients." Journal of Dual Diagnosis 3, no. 2 (March 22, 2007): 125–36. http://dx.doi.org/10.1300/j374v03n02_14.

Full text

APA, Harvard, Vancouver, ISO, and other styles

15

Carey, Kate B., and Michael P. Carey. "Social problem-solving in dual diagnosis patients." Journal of Psychopathology and Behavioral Assessment 12, no. 3 (September 1990): 247–54. http://dx.doi.org/10.1007/bf00960621.

Full text

APA, Harvard, Vancouver, ISO, and other styles

16

Chiauzzi, Emil. "Brief inpatient treatment of dual diagnosis patients." New Directions for Mental Health Services 1994, no. 63 (1994): 47–57. http://dx.doi.org/10.1002/yd.23319946306.

Full text

APA, Harvard, Vancouver, ISO, and other styles

17

Jones, D. H., C. Crichton, A. Macdonald, S. Potts; D. Sime, J. Toms, and J. McKinlay. "Teledermatology in the Highlands of Scotland." Journal of Telemedicine and Telecare 2, no. 1_suppl (June 1996): 7–9. http://dx.doi.org/10.1177/1357633x9600201s03.

Full text

Abstract:

A pilot study of telemedicine consultations of 51 dermatology patients showed that the technology worked well, with the diagnosis being able to be made in most patients and over half of the patients being able to be dealt with through this medium only. It could therefore have a valuable screening role. However, many of the patients, in spite of the obvious advantage of an immediate consultant opinion, felt it would be more appropriately used as a review technique.

APA, Harvard, Vancouver, ISO, and other styles

18

Pinderup, Pernille. "Challenges in working with patients with dual diagnosis." Advances in Dual Diagnosis 11, no. 2 (May 21, 2018): 60–75. http://dx.doi.org/10.1108/add-11-2017-0021.

Full text

Abstract:

Purpose Studies have shown that mental health professionals find working with patients with dual diagnosis challenging, and the purpose of this paper is to examine some of these challenges. Design/methodology/approach In total, 85 mental health professionals from 8 different mental health centres in Denmark were interviewed. The data analysis was inspired by a grounded theory approach. Findings Different challenges in the dual diagnosis treatment were identified and they suggested that the focus of treatment was mainly on the mental illness rather than the substance use disorder. The single focus of the treatment made it challenging to treat patients with dual diagnosis sufficiently. While several studies explain the single focus by inadequate competencies among professionals, the present study suggests that the single focus is also explained by the way that the treatment is organised. For instance, standardized treatment packages and insufficient guidelines on substance abuse treatment make it challenging to treat patients with dual diagnosis. Originality/value This paper suggests that a more flexible, and a longer period of, treatment, together with more sufficient guidelines on dual diagnosis treatment and a more formalized collaboration with the substance abuse treatment centres, will make it a less challenging issue to treat patients with dual diagnosis.

APA, Harvard, Vancouver, ISO, and other styles

19

Lehman, Anthony F., C. Patrick Myers, Jeannette Johnson, and Lisa B. Dixon. "Service Needs and Utilization for Dual-Diagnosis Patients." American Journal on Addictions 4, no. 2 (February 18, 2010): 163–69. http://dx.doi.org/10.1111/j.1521-0391.1995.tb00448.x.

Full text

APA, Harvard, Vancouver, ISO, and other styles

20

Taylor, Stephen M., Marc Galanter, Helen Dermatis, Neal Spivack, and Susan Egelko. "Dual Diagnosis Patients in the Modified Therapeutic Community." Journal of Addictive Diseases 16, no. 3 (July 1997): 31–38. http://dx.doi.org/10.1300/j069v16n03_04.

Full text

APA, Harvard, Vancouver, ISO, and other styles

21

Adams, David H., Hong Liu-Seifert, and Bruce J. Kinon. "Dual Diagnosis Patients in Clinical Trials of Antipsychotics." Journal of Dual Diagnosis 3, no. 2 (March 22, 2007): 73–83. http://dx.doi.org/10.1300/j374v03n02_09.

Full text

APA, Harvard, Vancouver, ISO, and other styles

22

Baigent, Michael. "Managing patients with dual diagnosis in psychiatric practice." Current Opinion in Psychiatry 25, no. 3 (May 2012): 201–5. http://dx.doi.org/10.1097/yco.0b013e3283523d3d.

Full text

APA, Harvard, Vancouver, ISO, and other styles

23

de Waal, Marleen M., Carolien Christ, Jack J. M. Dekker, Martijn J. Kikkert, Nick M. Lommerse, Wim van den Brink, and Anna E. Goudriaan. "Factors associated with victimization in dual diagnosis patients." Journal of Substance Abuse Treatment 84 (January 2018): 68–77. http://dx.doi.org/10.1016/j.jsat.2017.11.001.

Full text

APA, Harvard, Vancouver, ISO, and other styles

24

Roncero, Carlos, Elena Ros-Cucurull, Lara Grau-López, Christian Fadeuilhe, and Miguel Casas. "Effectiveness of Inhaled Loxapine in Dual-Diagnosis Patients." Clinical Neuropharmacology 39, no. 4 (2016): 206–9. http://dx.doi.org/10.1097/wnf.0000000000000153.

Full text

APA, Harvard, Vancouver, ISO, and other styles

25

Bachmann, K. M., H. P. Hirsbrunner, F. Moggi, R. Donati, J. Brodbeck, C. Meier, and M. Schneider. "A New Diagnostic Instrument for Dual-Diagnosis Patients." European Psychiatry 12, S2 (1997): 220s. http://dx.doi.org/10.1016/s0924-9338(97)80692-x.

Full text

APA, Harvard, Vancouver, ISO, and other styles

26

Levy, Michael, Ruth Saemann, and Godehard Oepen. "Neurological Comorbidity in Treatment-Resistant Dual Diagnosis Patients." Journal of Psychoactive Drugs 28, no. 2 (April 1996): 103–10. http://dx.doi.org/10.1080/02791072.1996.10524383.

Full text

APA, Harvard, Vancouver, ISO, and other styles

27

Lehman, Anthony F., C. Patrick Myers, Jeannette Johnson, and Lisa B. Dixon. "Service Needs and Utilization for Dual-Diagnosis Patients." American Journal on Addictions 4, no. 2 (January 1995): 163–69. http://dx.doi.org/10.3109/10550499508997439.

Full text

APA, Harvard, Vancouver, ISO, and other styles

28

de Waal, Marleen Maria, Jacobus Johannes Maria Dekker, and Anna Emma Goudriaan. "Prevalence of Victimization in Patients With Dual Diagnosis." Journal of Dual Diagnosis 13, no. 2 (December 28, 2016): 119–23. http://dx.doi.org/10.1080/15504263.2016.1274067.

Full text

APA, Harvard, Vancouver, ISO, and other styles

29

Levy, Michael. "Psychotherapy with dual diagnosis patients: Working with denial." Journal of Substance Abuse Treatment 10, no. 6 (November 1993): 499–504. http://dx.doi.org/10.1016/0740-5472(93)90052-4.

Full text

APA, Harvard, Vancouver, ISO, and other styles

30

Lopes, J., and R. Freitas. "Dual Diagnosis, Double Trouble." European Psychiatry 65, S1 (June 2022): S471. http://dx.doi.org/10.1192/j.eurpsy.2022.1197.

Full text

Abstract:

Introduction Many individuals with severe mental illness (SMI) have substance use disorder comorbidity. Dual diagnosis makes the approach and management of these patients even more challenging since the lack of improvement in either pathologies can lead to a deterioration of both. Objectives To illustrate, through the presentation of two cases, the clinical challenges in managing a patient with dual diagnosis Methods Clinical case presentation through retrospective review of clinical notes and non-systematic literature review on this topic Results We present the clinical cases of two women diagnosed with Bipolar Disorder and (poly)Substance Use Disorder since adolescence, who have a history of multiple hospitalizations due to mostly maniform symptoms. The complexity of case management is evident, both at the pharmacological level and in psychosocial intervention. This is aggravated by the difficulty in maintaining adherence to the therapeutic project and frequent relapses. Conclusions Current evidence points to the beneficial effect of a combined pharmacological and psychosocial approach, which must be comprehensive, individualized and require differentiation at various levels that are difficult to achieve and make the treatment of these situations an even greater challenge. Using illustrative examples, this review draws attention to the practical difficulties in managing situations where substance use is associated with SMI. Disclosure No significant relationships.

APA, Harvard, Vancouver, ISO, and other styles

31

Álvarez, F. J., and J. C. Valderrama. "Tratamientos de los pacientes con patología dual Treatments of patients with dual diagnosis." Trastornos Adictivos 9, no. 2 (June 2007): 73–74. http://dx.doi.org/10.1016/s1575-0973(07)75633-7.

Full text

APA, Harvard, Vancouver, ISO, and other styles

32

Lehman, Anthony F., C. Patrick Myers, Lisa B. Dixon, and Jeannette L. Johnson. "Defining Subgroups of Dual Diagnosis Patients for Service Planning." Psychiatric Services 45, no. 6 (June 1994): 556–61. http://dx.doi.org/10.1176/ps.45.6.556.

Full text

APA, Harvard, Vancouver, ISO, and other styles

33

Modestin, Jiri, Christoph J. Studer Gladen, and Stephan Christen. "A Comparative Study on Schizophrenic Patients with Dual Diagnosis." Journal of Addictive Diseases 20, no. 4 (December 3, 2001): 45–55. http://dx.doi.org/10.1300/j069v20n04_05.

Full text

APA, Harvard, Vancouver, ISO, and other styles

34

Eggink, Esmé, Marleen M. de Waal, and Anna E. Goudriaan. "Criminal offending and associated factors in dual diagnosis patients." Psychiatry Research 273 (March 2019): 355–62. http://dx.doi.org/10.1016/j.psychres.2019.01.057.

Full text

APA, Harvard, Vancouver, ISO, and other styles

35

Wolfe, Harriet L., and James L. Sorensen. "Dual Diagnosis Patients in the Urban Psychiatric Emergency Room." Journal of Psychoactive Drugs 21, no. 2 (April 1989): 169–75. http://dx.doi.org/10.1080/02791072.1989.10472157.

Full text

APA, Harvard, Vancouver, ISO, and other styles

36

Osuji, I. Julian, Elizabeth Vera-Bolaños, Thomas J. Carmody, and E. Sherwood Brown. "Pregnenolone for cognition and mood in dual diagnosis patients." Psychiatry Research 178, no. 2 (July 2010): 309–12. http://dx.doi.org/10.1016/j.psychres.2009.09.006.

Full text

APA, Harvard, Vancouver, ISO, and other styles

37

Levy, Michael S. "Engaging Dual Diagnosis Patients into Treatment: The T.E.E.A.C.H. Program." Journal of Psychoactive Drugs 34, no. 4 (December 1, 2002): 409–13. http://dx.doi.org/10.1080/02791072.2002.10399982.

Full text

APA, Harvard, Vancouver, ISO, and other styles

38

Delicato, C., E. Gattoni, S. Di Marco, C. Vecchi, A. Venesia, P. Zeppegno, and C. Gramaglia. "Resilience and Psychological Correlates in a Group of Patients Affected by Dual Diagnosis." European Psychiatry 41, S1 (April 2017): S202. http://dx.doi.org/10.1016/j.eurpsy.2017.01.2153.

Full text

Abstract:

IntroductionAlthough several authors found a strong association between childhood trauma and substance abuse disorder, many other suggest that specific personological aspects and resilience may contribute to the development of this disease.ObjectivesTo compare the characteristics of psychiatric patients with and without dual diagnosis assessing differences in psychological correlates, such as resilience, coping strategies, self-esteem, temperament, character traits and childhood trauma.MethodsFrom November 2015 to May 2016, we recruited all patients aged between 18 to 65 years referred to the Psychiatry Ward of “Maggiore della Carità” Hospital in Novara, Italy. Diagnosis of psychiatric disorder was made according to DSM-5 diagnostic criteria. Exclusion criteria were: inability to express a valid inform consent, a personality disorder or mental retardation diagnosis. We administered to each patient: Resilience Scale for Adult (RSA), Brief Cope, Rosenberg Self-esteem Scale (RSES), Childhood Trauma Questionnaire (CTQ), Temperament and Character Inventory (TCI). Patients were subdivided for the analysis into two groups: dual diagnosis and no dual diagnosis (or single diagnosis) group.ResultsData show that dual-diagnosis patients (n = 40) had lower global levels of resilience (RSA) and cooperativeness (TCI). Higher novelty seeking and reward dependence traits (TCI) were found as well. Moreover, the lower Cope-Avoidance (Brief Cope) was statistically different among patients with dual diagnosis compared to single diagnosis ones.ConclusionsIdentified differences between these two groups could suggest targets to manage during the treatments in order to optimise dual diagnosis patients’ outcomes.Disclosure of interestThe authors have not supplied their declaration of competing interest.

APA, Harvard, Vancouver, ISO, and other styles

39

Clafferty, Robert A., Elaine McCabe, and Keith W. Brown. "Conspiracy of silence? Telling patients with schizophrenia their diagnosis." Psychiatric Bulletin 25, no. 9 (September 2001): 336–39. http://dx.doi.org/10.1192/pb.25.9.336.

Full text

Abstract:

Aims and MethodWe undertook a postal questionnaire survey of all consultant psychiatrists working in Scotland to examine whether psychiatrists themselves may contribute to the misunderstandings surrounding schizophrenia by avoiding discussion of the diagnosis with their patients.ResultsTwo-hundred and forty-six (76%) responded. Ninety-five per cent thought the consultant psychiatrist was the most appropriate person to tell a patient their diagnosis of schizophrenia, although only 59% reported doing so in the first established episode of schizophrenia, rising to 89% for recurrent schizophrenia. Fifteen per cent would not use the term ‘schizophrenia’ and a variety of confusing terminology was reported. Over 95% reported telling patients they had mood disorders or anxiety, under 50% that they had dementia or personality disorders.Clinical ImplicationGreater openness by psychiatrists about the diagnosis of schizophrenia may be an essential first step in reducing stigma.

APA, Harvard, Vancouver, ISO, and other styles

40

Cross, S. J., and N. R. Waugh. "Hypothermia in the North East of Scotland." Scottish Medical Journal 41, no. 6 (December 1996): 167–68. http://dx.doi.org/10.1177/003693309604100604.

Full text

Abstract:

The aim of the study was to establish the incidence of hypothermia in the Grampian region, and to examine the accuracy of routine reporting of hypothermia on hospital discharge records. From 1990–1994, 167 patients were admitted with an SMRI diagnosis of hypothermia. An admission temperature of under 35°C was recorded in 47 (28%): rectal in 37 (confirmed hypothermia) and not specified on non-rectal in 10 (possible hypothermia). Most admissions were during the winter months In only 18 cases of the 47 patients with confirmed or possible hypothermia was a secondary cause not apparent. Isolated hypothermia is rare in Grampian. In most cases other disease is the underlying cause.

APA, Harvard, Vancouver, ISO, and other styles

41

Duncan, A., A. J. Morris, A. Cameron, M. J. Stewart, W. G. Brydon, and R. I. Russell. "Laxative Induced Diarrhoea-A Neglected Diagnosis." Journal of the Royal Society of Medicine 85, no. 4 (April 1992): 203–5. http://dx.doi.org/10.1177/014107689208500408.

Full text

Abstract:

A laxative screening service was established and offered to gastroenterologists in hospitals covering the West and Central belt of Scotland. The prevalence of laxative induced diarrhoea was assessed in two populations and was found to be 4% in new patients presenting to a gastroenterology clinic with diarrhoea and 20% in patients already under investigation of chronic idiopathic diarrhoea. A high rate of missed diagnosis of laxative induced diarrhoea (71%) and a low request rate (eight per annum) confirm the low clinical awareness of this diagnosis. We found potential savings of 80% of the cost of investigations subsequently ordered which could have been avoided by performing laxative screens on all patients presenting with diarrhoea. The introduction of such a screening policy is recommended as a cost-effective measure.

APA, Harvard, Vancouver, ISO, and other styles

42

Gomez Revuelta, M., M. Juncal Ruiz, O. Porta Olivares, L. Sanchez Blanco, D. Abejas Diez, G. Pardo de Santayana Jenaro, R. Landera Rodriguez, N. I. Nuñez Morales, and L. Garcia Ayala. "Dual Diagnosis and Medical Co-morbidity: Data from a Specialized Brief Psychiatric In-patient Unit." European Psychiatry 41, S1 (April 2017): S137. http://dx.doi.org/10.1016/j.eurpsy.2017.01.1963.

Full text

Abstract:

IntroductionPrevious research on the prevalence of medical disorders among adults with dual diagnosis (DD) has been inconclusive.ObjectivesThe purpose of this study was to assess dual diagnosis and medical co-morbidity at the Brief Psychiatric Inpatient Unit of Marqués de Valdecilla Hospital, Santander in the period from January 2014 until March 2015.MethodsNinety-three patients were admitted at our hospital from December 2014 until March 2015. The simple was analyzed retrospectively. Sixty-two of the patients (66.7%) met criteria for Dual Diagnosis. We collected socio-demographic variables, drug abuse, mental pathology, and treatment received.ResultsThe mean age of the sample was 42.95 years (± 14 DS) with a male:female ratio of 1.8:1 (no significant differences by gender). Hypertension was more prevalent among patients without dual pathology (22.5%). Patients with dual diagnosis presented hypertension less likely (6.5%) (P < 0.005). This can be explained by the fact that patients without dual diagnosis had a higher mean age (47 years) than patients with dual diagnosis (42 years). We did not found statistically significant differences between both groups respect to diabetes mellitus, vascular brain disease, HIV and dyslipidemia.ConclusionsHypertension was less likely to appear among patients with dual pathology admitted to an ultra brief psychiatry unit. This could be explained for an earlier mean age at admission among these patients.Disclosure of interestThe authors have not supplied their declaration of competing interest.

APA, Harvard, Vancouver, ISO, and other styles

43

Barral, C., L. Grau-López, L. Miquel, D. Bachiller, F. Gideoni, C. Rodríguez-Domínguez, L. Rodríguez-Martos, E. Ros, L. Laviña, and C. Roncero. "Sociodemographic and psychopatology features of outpatients dual diagnosis." European Psychiatry 26, S2 (March 2011): 10. http://dx.doi.org/10.1016/s0924-9338(11)71721-7.

Full text

Abstract:

IntroductionDual diagnosis patients are characterized by low rates of adherence and treatment compliance. During last years new resources have dedicated to these patients where substance use and mental disorder are treated simultaneously.ObjectivesThe aim of this study is to describe sociodemographic and psychopatology features of dual diagnosis outpatient.MethodsAll subjects in the study were outpatients at dual diagnosis program at Vall d’Hebron University Hospital, Barcelona, Spain during 2007 to 2008. These patients were following up until December 2009. Sociodemographic data, psychiatric diagnosis and substance abuse were assessed by using EuropASI, SCID-I y SCID-II and by reviewing their medical histories.ResultsA total of 90 patients were recruited for this study during 2007–2008 and were followed one year. 62,5% of them remain until the end of the treatment. 67,9% were men, medium age was 37 years old (± 1.4). Most of them live with their own families (57,1%) and their marital status was single (48,2%). In this sample the most prevalent psychiatric diagnosis was Major Depressive Disorder (36,4%) followed by Psychotic Disorder (36,2%). The most abused substance was cocaine (33,9%) followed by cannabis (26,8%), alcohol (16,1%), heroin (17,9%). More of 60% were polydrug.ConclusionsThe patients who maintained inculcation with the outpatient program of dual diagnosis were men with medium level of academic level and good family and social environment.

APA, Harvard, Vancouver, ISO, and other styles

44

Al Sayegh, Amal, and David Reid. "Prevalence of catatonic signs in acute psychiatric patients in Scotland." Psychiatrist 34, no. 11 (November 2010): 479–84. http://dx.doi.org/10.1192/pb.bp.109.025908.

Full text

Abstract:

Aims and methodConcerns have been raised that catatonia is underdiagnosed. Prevalence varies (1.3-32%) depending on diagnostic criteria. We used the Modified Rogers Scale to rate catatonic signs in patients consecutively admitted to three psychiatric wards over a 10-month period.ResultsThe prevalence of patients demonstrating any catatonic signs was at least 7.9-19.1%. The most common catatonic signs were marked underactivity (not sedated), echolalia/palilalia, marked overactivity (not restlessness) and gegenhalten. In those with catatonic signs, the most common diagnoses were schizophrenia, schizoaffective disorder and dementia.Clinical implicationsMost of the most common catatonic signs in our sample were motor signs. Antipsychotic-induced motor signs reflect interaction between drug and disease. Catatonic signs are not anchored in any one diagnosis and are on a spectrum of severity and quantity. Prevalence of these signs is higher than often presumed.

APA, Harvard, Vancouver, ISO, and other styles

45

Leon, Scott C., John S. Lyons, Nina J. Christopher, and Sheldon I. Miller. "Psychiatric Hospital Outcomes of Dual Diagnosis Patients Under Managed Care." American Journal on Addictions 7, no. 1 (January 1998): 81–86. http://dx.doi.org/10.3109/10550499809034715.

Full text

APA, Harvard, Vancouver, ISO, and other styles

46

Luoto, Kaisa E., Antti Koivukangas, Antero Lassila, and Olli Kampman. "Outcome of patients with dual diagnosis in secondary psychiatric care." Nordic Journal of Psychiatry 70, no. 6 (April 6, 2016): 470–76. http://dx.doi.org/10.3109/08039488.2016.1160149.

Full text

APA, Harvard, Vancouver, ISO, and other styles

47

Alger, Ian. "Rehabilitating Dual Diagnosis Patients in the Community; Understanding Group Therapy." Psychiatric Services 44, no. 4 (April 1993): 332–36. http://dx.doi.org/10.1176/ps.44.4.332.

Full text

APA, Harvard, Vancouver, ISO, and other styles

48

Alger, Ian. "Rehabilitating Dual Diagnosis Patients in the Community; Understanding Group Therapy." Psychiatric Services 44, no. 6 (June 1993): 597—a—597. http://dx.doi.org/10.1176/ps.44.6.597-a.

Full text

APA, Harvard, Vancouver, ISO, and other styles

49

Bogenschutz, Michael P., and Susan L. Siegfreid. "Factors Affecting Engagement of Dual Diagnosis Patients in Outpatient Treatment." Psychiatric Services 49, no. 10 (October 1998): 1350–52. http://dx.doi.org/10.1176/ps.49.10.1350.

Full text

APA, Harvard, Vancouver, ISO, and other styles

50

Leon, Scott C., John S. Lyons, Nina J. Christopher, and Sheldon I. Miller. "Psychiatric Hospital Outcomes of Dual Diagnosis Patients Under Managed Care." American Journal on Addictions 7, no. 1 (January 1998): 81–86. http://dx.doi.org/10.1111/j.1521-0391.1998.tb00470.x.

Full text

APA, Harvard, Vancouver, ISO, and other styles

We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!